Kallel Faouzi, Hamza Fatma, Charfeddine Salma, Amouri Wissem, Jardak Issam, Ghorbel Abdelmonem, Guermazi Fadhel
Department of Nuclear Medicine, Habib Bourguiba Hospital, Sfax-Tunisia.
Department of Oto-Rhino-Laryngology, Habib Bourguiba Hospital, Sfax-Tunisia.
Indian J Endocrinol Metab. 2014 Mar;18(2):185-90. doi: 10.4103/2230-8210.129109.
The differentiated thyroid cancers have a good prognosis unless the presence of metastasis. These distant metastases, especially in bone, are a major cause of impaired quality of life and death requiring intensive management. The aim of our work was to study the patients' data, the disease characteristics and to analyze the therapeutic management of these patients.
This study concerned a cohort of 21 patients treated for differentiated thyroid cancer during the period from 1995 to 2011. Eighteen of our patients were aged over 45 years. A majority of them had follicular carcinoma. Bone metastases were often multiple and located at the axial skeleton. They were associated with other types of metastases, especially lung metastasis. A majority of patients received 131I treatment, following surgery or external beam radiotherapy for a palliative purpose. Overall survival was 65% at 5 years and 49% at 10 years. A long-term survival was achieved in 10% of the patients benefiting from a multidisciplinary care adapted to each case.
Bone metastases often have a pejorative turning in the natural history of differentiated thyroid cancers. The right selection of individuals with better prognosis, for whom more aggressive curative treatment was indicated, requires a better understanding of the features of bone involvement.
分化型甲状腺癌预后良好,除非发生转移。这些远处转移,尤其是骨转移,是导致生活质量下降和死亡的主要原因,需要进行强化治疗。我们研究的目的是分析这些患者的临床资料、疾病特征,并探讨其治疗方法。
本研究纳入了1995年至2011年间接受分化型甲状腺癌治疗的21例患者。其中18例患者年龄超过45岁。大多数患者为滤泡状癌。骨转移常为多发,位于中轴骨骼。骨转移常伴有其他类型的转移,尤其是肺转移。大多数患者在手术后或姑息性外照射放疗后接受了131I治疗。5年总生存率为65%,10年总生存率为49%。10%的患者通过个体化多学科治疗获得了长期生存。
骨转移在分化型甲状腺癌的自然病程中往往预后不良。正确选择预后较好、适合更积极根治性治疗的患者,需要更好地了解骨转移的特征。